Geriatric Oncology Consortium   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Tampa FL United States (2001)

Organization Overview

First Clinical Trial
2004
NCT00215709
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Neoplasm Metastasis (Phase 2)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 10